IL21 and diffuse large B-cell lymphoma: However, in more advanced malignancy stages, such as diffuse large B-cell lymphoma (DLBCL), IL-21 has been shown to exhibit anti-cancer activity by downregulating anti-apoptotic genes and promoting apoptosis, as well as growth arrest [64,67,68,69,70,71,72,73].